Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cosciens Biopharma Inc (CSCI)

Cosciens Biopharma Inc (CSCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
COSCIENS Biopharma Inc. Appoints Global Consumer Products and Biosciences Executive, Anna Biehn as Chief Executive Officer

CSCI.TO : 4.61 (-6.87%)
CSCI : 3.46 (-2.54%)
COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update

CSCI.TO : 4.61 (-6.87%)
CSCI : 3.46 (-2.54%)
COSCIENS Biopharma Inc. Announces Receipt of Management Cease Trade Order

CSCI.TO : 4.61 (-6.87%)
CSCI : 3.46 (-2.54%)
COSCIENS Biopharma Inc. Announces Possible Delay in Filing Year-End Reporting Documents

Toronto, Ontario--(Newsfile Corp. - March 19, 2025) - COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) ("COSCIENS" or the "Company"), a life science company which develops and commercializes a diversified...

CSCI.TO : 4.61 (-6.87%)
CSCI : 3.46 (-2.54%)
COSCIENS Biopharma Inc. Announces Possible Delay in Filing Year-End Reporting Documents

CSCI.TO : 4.61 (-6.87%)
CSCI : 3.46 (-2.54%)
Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week

Positive data from clinical trials, earnings readouts, M&A speculation and new research drew heavy interest from retail traders on Stocktwits for these tickers for the week ended March 14, 2025.

TNYA : 0.4111 (-0.68%)
CSCI : 3.46 (-2.54%)
MLYS : 15.01 (+2.46%)
SWTX : 46.12 (-0.30%)
MGX : 1.5500 (+2.65%)
COSCIENS Biopharma Inc. Announces Successful Phase 1 Results Supporting Initiation of Phase 2a Clinical Efficacy Trial with Avenanthramides as a Potential Anti-Inflammatory Product

CSCI.TO : 4.61 (-6.87%)
CSCI : 3.46 (-2.54%)
COSCIENS Biopharma Inc. Provides Corporate Update and Highlights Pipeline Prioritization

CSCI.TO : 4.61 (-6.87%)
CSCI : 3.46 (-2.54%)
COSCIENS Biopharma Inc. Reports Third Quarter 2024 Financial Results and Provides Update on Advancements with Merger Integration Process and Ongoing Development Programs

CSCI.TO : 4.61 (-6.87%)
CSCI : 3.46 (-2.54%)
COSCIENS Biopharma Announces Change to Board of Directors

CSCI.TO : 4.61 (-6.87%)
CSCI : 3.46 (-2.54%)

Barchart Exclusives

Marjorie Taylor Greene Just Bought More Tesla Stock. Should You?
Is Greene’s latest Tesla trade a cue that should spark investor action on the EV stock? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar